A promising drug for the treatment of severe lung inflammation in COVID-19 patients
Montefiore Health System and Albert Einstein College of Medicine are the first sites in the nation to begin evaluating an investigational drug in two separate, FDA-approved trials: one to treat mild-to-moderate cases of COVID-19 ...
May 25, 2020
0
75